3rd Annual Opioid Use Disorder Conference
April 11, 2025
Kleberg Auditorium
Baylor College of Medicine
Main Campus
One Baylor Plaza
Houston, TX 77030
The opioid use epidemic has been on the forefront of societal concerns in the US. With the DEA-MATE act, all providers have to be able to adeptly prescribe and manage Opioid Use Disorder and related issues, which have proliferated. Treating teams face multiple challenges including need to treat chronic pain, over prescription of opioids and need for effective alternatives, and illicit use of opioids. The focus of this conference is pharmacological, psychotherapeutic treatments of OUD along with overviews of impact on families and children. We are proud to involve multiple community organizations that provide substance use treatments so attendees can have a comprehensive view of how to get patients effective OUD treatments in and out of the medical system. A main goal for the attendees is to be empowered and confident to initiate and/or maintain treatments for OUD.
This conference will help attendees earn the education credits in pain management and the prescription of opioids needed for the DEA-MATE act.
| Time | Name | Lecture Title/Scope |
|---|---|---|
| 7:45 - 8:10 a.m. | Breakfast | |
| 8:10 - 8:20 a.m. | Nidal Moukaddam, M.D., PhD. & Asim Shah, M.D. | Conference Intro |
| 8:20 - 8:30 a.m. | Sandeep Markan, M.D. | Intro on behalf of Harris Health/BCM |
| 8:30 - 8:55 a.m. | POP Health- Jessica Granger | The scope of OUD treatment in the county |
| 9 - 9:25 a.m. | Chethan Bachireddy, M.D. | Intersection between Hepatitis C and Opioid Use Disorder nationally and locally at Harris Health |
| 9:30 - 9:55 a.m. | UT-HEROES: Christine Bakos-Block, M.D. & Crystal Walsh | How UTH Heroes is responding to the opioid crisis in Houston and across the state |
| 10 - 10:25 a.m. | Coffee Break | |
| 10:30 - 10:55 a.m. | Greg Buehler, M.D. & Karen Jeoffroy, M.D. | Managing Opioid Withdrawal in the Emergency Department: ED-Initiated Buprenorphine |
| 11 - 11:25 a.m. | Benjamin Li, M.D. & Michèle Haykal, M.D. | What do buprenorphine levels really tell us? Quantitative analyses in relation to clinical response |
| 11:30 - 11:55 a.m. | Nidal Moukaddam, M.D., PhD. | Technology advances in substance use treatment |
| 12 - 12:25 p.m. | Kelly Truong, M.D. | Co-occurring Stimulant and Opioid use disorders- a clinical challenge |
| 12:30-1:30 p.m. | Lunch | |
| 1:30-1:55p | To be announced | DEA/SAMSHA Regional perspective |
| 2 - 2:25 p.m. | Alicia Kowalchuk, D.O. | Santa Maria Hostel: providing community-based, specialized SUD treatment for women and their families |
| 2:30 - 2:55 p.m. | Edore Onigu-Otite, M.D. | ADHD, Opioids, and the Family: Protecting Vulnerable Youth. |
| 3 - 3:25 p.m. | Megan Britton, PhD. | Implementation of a tobacco-free workplace program in opioid treatment centers in Texas: Findings and future directions |
| 3:30 - 3:55 p.m. | Joel Kanter, Pharm. D. | Co-Occurrence of Benzodiazepines, Gabapentinoids, and Opioid Use Disorder: |
*CME provided, conference is free but registration needed.
Breakfast and lunch will be provided.
For questions or inquiries, please contact Michele Haykal.
